STRIDES PHARMA SCIENCE
|
|
BOM : 532531     NSE : STAR     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward Pledged Shares : High [>50%] |
Mar 27,2025 |
Price(EOD): ₹ 655.65
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 6,045.09 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
STRIDES PHARMA SCIENCE | -6.5% | 1.9% | -12.4% |
SUN PHARMACEUTICAL INDUSTRIES | -3% | 5.6% | 9.3% |
DIVIS LABORATORIES | 1% | 2.7% | 70.3% |
CIPLA | -2.7% | 0.4% | -0.4% |
TORRENT PHARMACEUTICALS | 0.1% | 7.2% | 25.7% |
DR REDDYS LABORATORIES | -3.1% | -0.2% | -6.2% |
MANKIND PHARMA | 2% | 7.1% | 8.8% |
ZYDUS LIFESCIENCES | -3% | 0.1% | -9.3% |
LUPIN | -4.6% | 6.1% | 28% |
FUNDAMENTAL ANALYSIS OF STRIDES PHARMA SCIENCE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF STRIDES PHARMA SCIENCE
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
18.06
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 334.62 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] 2.85
P/B Calculated based on Book Value of Rs 2,122.47 Cr
[Latest Year - Mar2024 - Consolidated Results ] 1.34
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 4,526.32 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-21% -51% -40% |
SHARE PRICE MOMENTUM OF STRIDES PHARMA SCIENCE
STRIDES PHARMA SCIENCE vs SENSEX
DEBT OF STRIDES PHARMA SCIENCE
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.45 0.39 0.37 0.4 |
1.14 1.27 1.18 1.2 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF STRIDES PHARMA SCIENCE
Pledged Promoter Shares |
54.25 % | |
---|---|---|
As on : Dec2024 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF STRIDES PHARMA SCIENCE
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-3.95% -10.81% -11.58% -16.33% |
14.7% 48.12% 424.5% 1441.58% |
QtrlyTrend |
0 | |
Latest Qtr: Dec2024 | ||
Quarterly Result Analysis → |
STRIDES PHARMA SCIENCE related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 3.8% | 3.5% | 9.2% |
BSE MIDSMALLCAP | 1% | 1.3% | 11.1% |
BSE SMALLCAP | 1% | 2.1% | 10.6% |
BSE HEALTHCARE | -0% | 4.7% | 21.7% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY TOTAL MARKET | 1.5% | 3.4% | 7.7% |
NIFTY MIDSMALL HEALTHCARE | 1% | 7% | 29.6% |
NIFTY MICROCAP 250 | -0.2% | 0.6% | 11.7% |
You may also like the below Video Courses
FAQ about STRIDES PHARMA SCIENCE
Is STRIDES PHARMA SCIENCE good for long term investment?
As on Mar 27,2025, the Fundamentals of STRIDES PHARMA SCIENCE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of STRIDES PHARMA SCIENCE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is STRIDES PHARMA SCIENCE UnderValued or OverValued?
As on Mar 27,2025, STRIDES PHARMA SCIENCE is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of STRIDES PHARMA SCIENCE ?
As on Mar 27,2025, the Intrinsic Value of STRIDES PHARMA SCIENCE is Rs. 1,099.26 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 825.80
Fair Value [Median EV / Sales Model] : Rs. 1,342.22
Fair Value [Median Price / Sales Model] : Rs. 1,099.26
Estimated Median Fair Value of STRIDES PHARMA SCIENCE : Rs. 1,099.26
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.